Corpus Intelligence IC Memo — UNIVERSITY HOSPITALS REHAB HOSPITAL 2026-04-27 02:41 UTC
IC Memo — UNIVERSITY HOSPITALS REHAB HOSPITAL
Investment Committee Memorandum | OH | 50 beds | Grade C | EBITDA uplift $1.6M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 363036

UNIVERSITY HOSPITALS REHAB HOSPITAL

LOCATIONCUYAHOGA, OH·BEDS50·AS OFApril 27, 2026
C
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

UNIVERSITY HOSPITALS REHAB HOSPITAL is a 50-bed suburban community hospital in CUYAHOGA, OH with $21.7M in net patient revenue and a 27.5% operating margin. The hospital serves a payer mix of 42.0% Medicare, 2.4% Medicaid, and 55.6% commercial.

Thesis: Turnaround. Our ML models identify $1.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 27.5% to 34.9% (+736bps).

Net Revenue HCRIS$21.7M
Current EBITDA COMPUTED$6.0M
Operating Margin COMPUTED27.5%
Occupancy HCRIS57.4%
Revenue / Bed COMPUTED$435K
Net-to-Gross HCRIS64.7%
Distress Probability ML51.4%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
109
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 27.5% places it above the state median. Among 109 size-comparable peers (25-100 beds), the median margin is -1.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (25-100), prioritizing same-state peers. 109 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UNIVERSITY HOSPITALS REHAB HOS (Target)OH50$21.7M27.5%
KNOX COMMUNITY HOSPITALOH64$196.0M-16.7%
CRYSTAL CLINIC ORTHOPAEDIC CENOH59$173.3M-14.9%
OBLENESS MEMORIAL HOSPITALOH67$160.9M29.9%
MEMORIAL HOSPITAL OF UNION COUOH51$151.0M8.0%
FISHER-TITUS MEDICAL CENTEROH78$148.3M-6.9%
WESTERN RESERVE HOSPITALOH83$147.6M-9.3%
GRADY MEMORIAL HOSPITALOH60$146.7M16.5%
ST. LUKES HOSPITALOH99$144.3M-27.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$456K+210bp18mo
Cost to Collect4.5%2.5%$435K+200bp12mo
Denial Rate Reduction12.0%6.5%$430K+198bp12mo
A/R Days Reduction5200.0%3800.0%$264K+122bp9mo
Clean Claim Rate88.0%96.0%$14K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$456K
Cost to Collect
$435K
Denial Rate Reduction
$430K
A/R Days Reduction
$264K
Clean Claim Rate
$14K
Total EBITDA Uplift$1.6M
Current EBITDA$6.0M
+ RCM Uplift+$1.6M
Pro Forma EBITDA$7.6M
Current Margin27.5%
Pro Forma Margin34.9%
WC Released (1x)$834K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$9.2M$55.5M6.03x43.2%
Base (11x exit)10.0x11.0x$9.2M$64.0M6.95x47.4%
Bull Case9.0x11.0x$8.3M$72.3M8.72x54.2%
Bull (12x exit)9.0x12.0x$8.3M$81.3M9.81x57.9%
Bear Case11.0x10.0x$10.1M$44.5M4.39x34.4%
Bear (11x exit)11.0x11.0x$10.1M$52.2M5.16x38.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 51.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 109 hospitals with 25-100 beds
  • Same-state prioritization (n=110)
  • Comp margins: P25=-13.9% / P50=-1.5% / P75=9.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.